retatrutide type 2 diabetes phase 2 trial 2024 results Effects of once-weekly subcutaneous on weight and metabolic markers: A systematic review and meta-analysis of randomized controlled trials Retatrutide: A Promising Option for – 💉 A triple-action once-weekly injection

2018 Aug 10;429:100-116

Safety and pharmacokinetics of single and multiple ascending doses of the novel oral human GLP-1 analogue, oral semaglutide, in healthy subjects and subjects with type 2 diabetes

Fred Sattler at University of Southern California Keck School of Medicine

I have been taking this product for about 6 months and have lost about 18 pounds

-Angiogenesis and Endothelial Protection The peptide promotes neovascularization by upregulating VEGFR2 and egr-1 pathways while stabilizing endothelial integrity under oxidative or inflammatory stress 1,2

doi: 10.1016/j.envexpbot.2018.08.016 65 LiuJ.LiF.LiangL.JiangY.ChenJ